Perception of Young European Otolaryngologists toward Transoral Robotic Surgery in Head and Neck Oncology and Surgery.
Jérôme René LechienAbdul-Latif HamdanNicolas FakhryLuigi Angelo VairaGiannicola IannellaIsabelle M GenglerJustin MichelThomas RadulescoMarc RemacleStephane HansGiovanni CammarotoAlberto Maria SaibeneMiguel Mayo YanezAntonino ManiaciPublished in: Journal of clinical medicine (2024)
Background : To investigate the perception of young European otolaryngologists (OTOs), i.e., head and neck surgeons, toward transoral robotic surgery (TORS). Methods : Members of the Young Confederation of European Otorhinolaryngology-Head and Neck Surgery and Young Otolaryngologists of International Federation of Otorhinolaryngological Societies were surveyed about TORS perception and practice. Results : The survey was completed by 120 young OTOS (26%). The most important barriers to TORS were robot availability (73%), cost (69%), and lack of training (37%). The participants believed that the main benefits include better surgical filed view (64%), shorter hospital stay (62%), and better postoperative outcomes (61%) than the conventional approach. Head and neck surgeons considered cT1-T2 oropharyngeal cancers (94%), resection of base of tongue for sleep apnea (86%), or primary unknown cancer (76%) as the most appropriate indications. A total of 67% of TORS surgeons assessed themselves as adequately trained in TORS. Conclusions : Young European OTOs report positive perception, adoption, and knowledge of TORS. The cost-related unavailability and the lack of training or access are reported to be the most important barriers for the spread of TORS.
Keyphrases
- middle aged
- sleep apnea
- healthcare
- quality improvement
- minimally invasive
- primary care
- obstructive sleep apnea
- type diabetes
- magnetic resonance imaging
- emergency department
- palliative care
- patients undergoing
- electronic health record
- acute coronary syndrome
- coronary artery disease
- insulin resistance
- positive airway pressure
- pet ct
- acute care
- young adults
- childhood cancer
- adverse drug
- squamous cell